CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 1993; 43:151
doi: 10.3322/canjclin.43.3.151
© 1993 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Richie, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Richie, J. P.

CA: A Cancer Journal for Clinicians, Vol 43, Issue 3 151-175, Copyright © 1993 by American Cancer Society


ARTICLES

Detection and treatment of testicular cancer

J. P. Richie
Division of Urological Surgery, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts.

The survival rate for testicular cancer has undergone a dramatic increase from 10 percent in the 1970s to 90 percent in the 1990s. This increase is due to improvements in clinical practice that have now made testicular cancer one of the most curable solid tumors. This article overviews the detection and treatment of testicular cancer, as well as its histology, epidemiology, and natural history.


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
A. M. Bach, L. E. Hann, W. Shi, C. S. Giess, H.-H. Yoo, J. Sheinfeld, and H. T. Thaler
Is There an Increased Incidence of Contralateral Testicular Cancer in Patients with Intratesticular Microlithiasis?
Am. J. Roentgenol., February 1, 2003; 180(2): 497 - 500.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
K. Nakamura, T. Taniguchi, Y. Funahashi, and K. Yoshimatsu
Effects of ER-37328 on Primary Tumor, Liver Metastasis, and Life Span in a Murine Colon 38 Orthotopic Transplantation Model
Mol. Cancer Ther., January 1, 2003; 2(1): 59 - 64.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
K. Nakamura, H. Sugumi, A. Yamaguchi, T. Uenaka, Y. Kotake, T. Okada, J. Kamata, J. Niijima, T. Nagasu, N. Koyanagi, et al.
Antitumor Activity of ER-37328, a Novel Carbazole Topoisomerase II Inhibitor
Mol. Cancer Ther., January 1, 2002; 1(3): 169 - 175.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
A. M. Bach, J. Sheinfeld, and L. E. Hann
Abnormal Testis at US in Patients after Orchiectomy for Testicular Neoplasm
Radiology, May 1, 2000; 215(2): 432 - 436.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by American Cancer Society.